The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
MCP-1: Function, regulation, and involvement in disease
Open accessAbstract
MCP-1 (Monocyte chemoattractant protein-1), also known as Chemokine (CC-motif) ligand 2 (CCL2), is from family of CC chemokines. It has a vital role in the process of inflammation, where it attracts or enhances the expression of other inflammatory factors/cells. It leads to the advancement of many disorders by this main mechanism of migration and infiltration of inflammatory cells like monocytes/macrophages and other cytokines at the site of inflammation. MCP-1 has been inculpated in the pathogenesis of numerous disease conditions either directly or indirectly like novel corona virus, cancers, neuroinflammatory diseases, rheumatoid arthritis, cardiovascular diseases. The elevated MCP-1 level has been observed in COVID-19 patients and proven to be a biomarker associated with the extremity of disease along with IP-10. This review will focus on involvement and role of MCP-1 in various pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Role of neuroinflammation in neurodegenerative diseases (Review)
CHEN, W.-W., ZHANG, X., & HUANG, W.-J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4948 · Cited by 932
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
(2000) · PubMed · Cited by 706
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Koch, A. E., Kunkel, S. L., Harlow, L. A., Johnson, B., Evanoff, H. L., Haines, G. K., Burdick, M. D., Pope, R. M., & Strieter, R. M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115950 · Cited by 668
Hoarau, J.-J., Jaffar Bandjee, M.-C., Krejbich Trotot, P., Das, T., Li-Pat-Yuen, G., Dassa, B., Denizot, M., Guichard, E., Ribera, A., Henni, T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900255 · Cited by 640
Insulin resistance causes inflammation in adipose tissue
Shimobayashi, M., Albert, V., Woelnerhanssen, B., Frei, I. C., Weissenberger, D., Meyer-Gerspach, A. C., Clement, N., Moes, S., Colombi, M., Meier, J. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96139 · Cited by 480 · cited 1×
“The insulin resistance due to obesity is a risk factor for type 2 diabetes [T2DM] which causes inflammation of adipose tissuemediated by the production of MCP-1 by adipocytes which results in recruitment of monocytes and activation of macrophages [41].”
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
Raghu, H., Lepus, C. M., Wang, Q., Wong, H. H., Lingampalli, N., Oliviero, F., Punzi, L., Giori, N. J., Goodman, S. B., Chu, C. R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210426 · Cited by 452
Dwyer, R. M., Potter-Beirne, S. M., Harrington, K. A., Lowery, A. J., Hennessy, E., Murphy, J. M., Barry, F. P., O'Brien, T., & Kerin, M. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0731 · Cited by 431
Differential CC chemokine-induced enhancement of T helper cell cytokine production
Karpus, W. J., Lukacs, N. W., Kennedy, K. J., Smith, W. S., Hurst, S. D., & Barrett, T. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4129 · Cited by 413
The MCP/eotaxin subfamily of CC chemokines
Van Coillie, E., Van Damme, J., & Opdenakker, G. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00005-2 · Cited by 350
Standiford, T. J., Kunkel, S. L., Phan, S. H., Rollins, B. J., & Strieter, R. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92905-4 · Cited by 349
Kwaifa, I. K., Bahari, H., Yong, Y. K., & Noor, S. M. (2020) · Biomolecules · doi:10.3390/biom10020291 · Cited by 345
Kang, S., Tanaka, T., Inoue, H., Ono, C., Hashimoto, S., Kioi, Y., Matsumoto, H., Matsuura, H., Matsubara, T., Shimizu, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010229117 · Cited by 330
Chemokine and cytokine levels in inflammatory bowel disease patients
Singh, U. P., Singh, N. P., Murphy, E. A., Price, R. L., Fayad, R., Nagarkatti, M., & Nagarkatti, P. S. (2016) · Cytokine · doi:10.1016/j.cyto.2015.10.008 · Cited by 316
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Chen, Y., Wang, J., Liu, C., Su, L., Zhang, D., Fan, J., Yang, Y., Xiao, M., Xie, J., Xu, Y., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00230-x · Cited by 297
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1345-4 · Cited by 295
CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis
Miller, R. E., Tran, P. B., Das, R., Ghoreishi-Haack, N., Ren, D., Miller, R. J., & Malfait, A.-M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209294110 · Cited by 276
Lindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.007 · Cited by 276
Wood, S., Jayaraman, V., Huelsmann, E. J., Bonish, B., Burgad, D., Sivaramakrishnan, G., Qin, S., DiPietro, L. A., Zloza, A., Zhang, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091574 · Cited by 249
Sokolova, A., Hill, M. D., Rahimi, F., Warden, L. A., Halliday, G. M., & Shepherd, C. E. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00188.x · Cited by 249
Tumur, Z., Shimizu, H., Enomoto, A., Miyazaki, H., & Niwa, T. (2010) · American Journal of Nephrology · doi:10.1159/000299798 · Cited by 246
ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · cited 1×
“MCP-1 is found in senile plaques and reactive microglia in AD [93].”
Loberg, R. D., Ying, C., Craig, M., Yan, L., Snyder, L. A., & Pienta, K. J. (2007) · Neoplasia · doi:10.1593/neo.07307 · Cited by 242
Monti, P., Leone, B. E., Marchesi, F., Balzano, G., Zerbi, A., Scaltrini, F., Pasquali, C., Calori, G., Pessi, F., Sperti, C., et al. (2003) · PubMed · Cited by 238
Tanuma, N., Sakuma, H., Sasaki, A., & Matsumoto, Y. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0083-7 · Cited by 237
Sadek, M. I., Sada, E., Toossi, Z., Schwander, S. K., & Rich, E. A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.3.2815 · Cited by 227
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease
Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209 · cited 1×
“(MCI) and mild AD, which lowers during progression of disease [94].”
Tian, D.-S., Peng, J., Murugan, M., Feng, L.-J., Liu, J.-L., Eyo, U. B., Zhou, L.-J., Mogilevsky, R., Wang, W., & Wu, L.-J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0315-17.2017 · Cited by 202
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Young, B. E., Ong, S. W. X., Ng, L. F. P., Anderson, D. E., Chia, W. N., Chia, P. Y., Ang, L. W., Mak, T.-M., Kalimuddin, S., Chai, L. Y. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1280 · Cited by 199
Lee, W.-J., Liao, Y.-C., Wang, Y.-F., Lin, I.-F., Wang, S.-J., & Fuh, J.-L. (2018) · Scientific Reports · doi:10.1038/s41598-018-19807-y · Cited by 193
Impact of MCP -1 in Atherosclerosis
Lin, J., Kakkar, V., & Lu, X. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140522115801 · Cited by 185
Sung, F. L., Zhu, T. Y., Au-Yeung, K. K. W., Siow, Y. L., & Karmin, O. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid577.x · Cited by 181
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy
Morii, T., Fujita, H., Narita, T., Shimotomai, T., Fujishima, H., Yoshioka, N., Imai, H., Kakei, M., & Ito, S. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00176-9 · Cited by 177
Fantuzzi, L., Borghi, P., Ciolli, V., Pavlakis, G., Belardelli, F., & Gessani, S. (1999) · Blood · doi:10.1182/blood.v94.3.875.415k28_875_883 · Cited by 171
Hall, S., Janelidze, S., Surova, Y., Widner, H., Zetterberg, H., & Hansson, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-31517-z · Cited by 168
Sims, J. T., Krishnan, V., Chang, C.-Y., Engle, S. M., Casalini, G., Rodgers, G. H., Bivi, N., Nickoloff, B. J., Konrad, R. J., de Bono, S., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.031 · Cited by 164
Grimm, M. C., Elsbury, S. K. O., Pavli, P., & Doe, W. F. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.6.804 · Cited by 163
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Fantuzzi, L., Tagliamonte, M., Gauzzi, M. C., & Lopalco, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03255-6 · Cited by 159
Koide, N., Nishio, A., Sato, T., Sugiyama, A., & Miyagawa, S.-I. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30733.x · Cited by 158
Traynor, T. R., Herring, A. C., Dorf, M. E., Kuziel, W. A., Toews, G. B., & Huffnagle, G. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4659 · Cited by 154
Barna, B. P., Pettay, J., Barnett, G. H., Zhou, P., Iwasaki, K., & Estes, M. L. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90220-8 · Cited by 146
Aukrust, P., Berge, R. K., Ueland, T., Aaser, E., Damås, J. K., Wikeby, L., Brunsvig, A., Müller, F., Forfang, K., Frøland, S. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01110-4 · Cited by 141
Khan, W., Motomura, Y., Wang, H., El–Sharkawy, R. T., Verdu, E. F., Verma–Gandhu, M., Rollins, B. J., & Collins, S. M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00069.2006 · Cited by 141
The role of C-C chemokines and their receptors in osteoarthritis
Yuan, G.-H., Masuko-Hongo, K., Sakata, M., Tsuruha, J.-I., Onuma, H., Nakamura, H., Aoki, H., Kato, T., & Nishioka, K. (2001) · Arthritis & Rheumatism · Cited by 138
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
Valković, T., Lučin, K., Krstulja, M., Dobi-Babić, R., & Jonjić, N. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80057-5 · Cited by 137
The Chemokine CCL2 Mediates the Seizure-enhancing Effects of Systemic Inflammation
Cerri, C., Genovesi, S., Allegra, M., Pistillo, F., Püntener, U., Guglielmotti, A., Perry, V. H., Bozzi, Y., & Caleo, M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0451-15.2016 · Cited by 133
Harigai, M., Hara, M., Yoshimura, T., Leonard, E. J., Inoue, K., & Kashiwazaki, S. (1993) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1993.1153 · Cited by 131
Tabrizi, Y. T., Hassanshahi, G., Kounis, N. G., Koniari, I. C., & Khorramdelazad, H. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-00500-8 · Cited by 131
Yoshimura, T., Howard, O. M. Z., Ito, T., Kuwabara, M., Matsukawa, A., Chen, K., Liu, Y., Liu, M., Oppenheim, J. J., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058791 · Cited by 124
Dutta, P., Sarkissyan, M., Paico, K., Wu, Y., & Vadgama, J. V. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4760-8 · Cited by 124
Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?
Маслов, Л. Н., Naryzhnaya, N. V., Boshchenko, A. A., Popov, S. V., Ivanov, V. V., & Oeltgen, P. R. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.11.001 · Cited by 116
Joly‐Amado, A., Hunter, J., Quadri, Z., Zamudio, F., Rocha-Rangel, P., Chan, D., Kesarwani, A., Nash, K. R., Lee, D. C., Morgan, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00997 · Cited by 111
Georgakis, M. K., van der Laan, S. W., Asare, Y., Mekke, J. M., Haitjema, S., Schoneveld, A. H., de Jager, S. C. A., Nurmohamed, N. S., Kroon, J., Stroes, E. S. G., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316091 · Cited by 111
Takebayashi, K., Matsumoto, S., Aso, Y., & Inukai, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1718 · Cited by 110
Scarpini, E. A., Galimberti, D., Baron, P., Clerici, R., Ronzoni, M., Conti, G. M., & Scarlato, G. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00680-3 · Cited by 110
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice
Zamara, E., Galastri, S., Aleffi, S., Petrai, I., Aragno, M., Mastrocola, R., Novo, E., Bertolani, C., Milani, S., Vizzutti, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.007 · Cited by 103
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Lü, Y., Chen, Q., Corey, E., Xie, W., Fan, J., Mizokami, A., & Zhang, J. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9226-7 · Cited by 102
Arefieva, T. I., Kukhtina, N. B., Antonova, O. A., & Krasnikova, T. L. (2005) · Cytokine · doi:10.1016/j.cyto.2005.06.016 · Cited by 100
Increases in a Pro-inflammatory Chemokine, MCP-1, Are Related to Decreases in Memory Over Time
Bettcher, B. M., Neuhaus, J. M., Wynn, M. J., Elahi, F. M., Casaletto, K. B., Saloner, R., Fitch, R., Karydas, A., & Kramer, J. H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00025 · Cited by 99
Jørgensen, M. J., Holter, J. C., Christensen, E. E., Schjalm, C., Tonby, K., Pischke, S. E., Jenum, S., Skeie, L. G., Nur, S., Lind, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78710-7 · Cited by 98
MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels
Fenoglio, C., Galimberti, D., Lovati, C., Guidi, I., Gatti, A., Fogliarino, S., Tiriticco, M., Mariani, C. B., Forloni, G., Pettenati, C., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.008 · Cited by 94
The CCL2‐CCR2 system affects the progression and clearance of intracerebral hemorrhage
Yao, Y., & Tsirka, S. E. (2012) · Glia · doi:10.1002/glia.22323 · Cited by 92
Anderberg, S. B., Luther, T., Berglund, M., Larsson, R. L., Rubertsson, S., Lipcsey, M., Larsson, A. O., Frithiof, R., & Hultström, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155389 · Cited by 92
Guo, F., Xu, D., Lin, Y., Wang, G., Wang, F., Gao, Q., Wei, Q., & Lei, S. (2019) · The FASEB Journal · doi:10.1096/fj.201902203rr · Cited by 91
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Santaella, A., Kuiperij, H. B., van Rumund, A., Esselink, R. A. J., van Gool, A. J., Bloem, B. R., & Verbeek, M. M. (2020) · BMC Neurology · doi:10.1186/s12883-020-1608-8 · Cited by 91
Chiarelli, F., Cipollone, F., Mohn, A., Marini, M., Iezzi, A., Fazia, M. L., Tumini, S., Cesare, D. D., Pomilio, M., Pierdomenico, S. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1829 · Cited by 90
Bettcher, B. M., Fitch, R., Wynn, M. J., Lalli, M. A., Elofson, J., Jastrzab, L., Mitic, L., Miller, Z. A., Rabinovici, G. D., Miller, B. L., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.05.004 · Cited by 89
Chemokines in CSF of Alzheimer's disease patients
Corrêa, J. D., Starling, D. S. V., Teixeira, A. L., Caramelli, P., & Silva, T. A. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000400009 · Cited by 85
Xu, Y., Ke, Y., Wang, B., & Lin, J. (2015) · Biological Research · doi:10.1186/s40659-015-0057-0 · Cited by 85
CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
Hasan, Z., Cliff, J. M., Dockrell, H. M., Jamil, B., Irfan, M., Ashraf, M., & Hussain, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008459 · Cited by 84
Favero, M., Belluzzi, E., Trisolino, G., Goldring, M. B., Goldring, S. R., Cigolotti, A., Pozzuoli, A., Ruggieri, P., Ramonda, R., Grigolo, B., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27766 · Cited by 83
Production of Monocyte Chemoattractant Protein 1 in Tuberculosis Patients
Lin, Y., Gong, J., Zhang, M., Xue, W., & Barnes, P. F. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2319-2322.1998 · Cited by 80
Akhter, N., Madhoun, A. S. A., Arefanian, H., Wilson, A., Kochumon, S., Thomas, R., Shenouda, S., Al‐Mulla, F., Ahmad, R., & Sindhu, S. T. A. K. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000117 · Cited by 80
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia
Dessing, M. C., van der Sluijs, K. F., Florquin, S., & van der Poll, T. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.001 · Cited by 79
Liu, J., Chen, P., Chang, T., & Hou, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01756-y · Cited by 79
Omata, N., Yasutomi, M., Yamada, A., Iwasaki, H., Mayumi, M., & Ohshima, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4861 · Cited by 76
Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis
Zhang, L., Yu, M., Deng, J., Lv, X., Liu, J., Xiao, Y., Yang, W., Zhang, Y., & Li, C. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.4.1134 · Cited by 75
Appleton, C. T., Usmani, S. E., Pest, M. A., Pitelka, V., Mort, J. S., & Beier, F. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39255 · Cited by 75
Absence of MCP‐1 leads to elevated bone mass via impaired actin ring formation
Sul, O., Ke, K., Kim, W.-K., Kim, S., Lee, S., Kim, H., Kim, S., Suh, J., & Choi, H. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22879 · Cited by 73
Yoshimura, T., & Takahashi, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1942 · Cited by 69
Watanabe, T., Higuchi, K., Hamaguchi, M., Shiba, M., Tominaga, K., Fujiwara, Y., Matsumoto, T., & Arakawa, T. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00372.2003 · Cited by 68
Stefano, A. D., Coccini, T., Roda, E., Signorini, C., Balbi, B., Brunetti, G., & Ceriana, P. (2018) · International Journal of COPD · doi:10.2147/copd.s159915 · Cited by 62
Host engulfment pathway controls inflammation in inflammatory bowel disease
Sayed, I. M., Suarez, K., Lim, E., Singh, S., Pereira, M. P., Ibeawuchi, S., Katkar, G. D., Dunkel, Y., Mittal, Y., Chattopadhyay, R., et al. (2020) · FEBS Journal · doi:10.1111/febs.15236 · Cited by 61
Self-citationIto, Y., Ishiguro, H., Kobayashi, N., Hasumi, H., Watanabe, M., Yao, M., & Uemura, H. (2015) · The Prostate · doi:10.1002/pros.22972 · Cited by 59
Futagami, S., Hiratsuka, T., Tatsuguchi, A., Suzuki, K., Kusunoki, M., Shinji, Y., Shinoki, K., Iizumi, T., Akamatsu, T., Nishigaki, H., et al. (2003) · Gut · doi:10.1136/gut.52.9.1257 · Cited by 59
Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis
Lee, Y. H., & Song, G. G. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-016-0109-z · Cited by 57
Dong, N., Li, X., Xiao, L., Yu, W., Wang, B., & Chu, L. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9446 · Cited by 56
Ji, W., Chen, H., Lin, C.-H., Lee, J., & Lee, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088952 · Cited by 55
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus
Lima, G., Soto‐Vega, E., Atisha‐Fregoso, Y., Sánchez‐Guerrero, J., Vallejo, M., Vargas‐Alarcón, G., & Llorente, L. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.10.007 · Cited by 50
Beall, C. J., MAHAJAN, S., Kuhn, D. E., & Kolattukudy, P. E. (1996) · Biochemical Journal · doi:10.1042/bj3130633 · Cited by 50
Bonifačić, D., Toplak, A., Horvat, I. B., Tokmadžić, V. S., Lekić, A., & Kučić, N. (2015) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0878-4 · Cited by 44
Yoshimura, T., Imamichi, T., Weiss, J. M., Sato, M., Li, L., Matsukawa, A., & Wang, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00002 · Cited by 41
Santaella, A., Kuiperij, H. B., van Rumund, A., Esselink, R. A. J., van Gool, A. J., Bloem, B. R., & Verbeek, M. M. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-00124-z · Cited by 41
MCP‐1 and CCR2 gene variants in oral squamous cell carcinoma
Bektas‐Kayhan, K., Unur, M., Metin, Z. B., & Çakmakoğlu, B. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01843.x · Cited by 37
Kumar, A., Shalmanova, L., Hammad, A., et al. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.02.003 · Cited by 37
Guan, R., Purohit, S. B., Wang, H., Bode, B. W., Reed, J. H. C., Steed, R. D., Anderson, S. W., Steed, L., Hopkins, D., Xia, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017822 · Cited by 36
Du, Z.-J., Wu, X., Song, M., Li, P., & Wang, L. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3508-6 · Cited by 35
Kimura, A., Yoshikura, N., Hayashi, Y., & Inuzuka, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170519 · Cited by 34
Critical Protective Role for MCP-1 in Pneumonic Burkholderia mallei Infection
Goodyear, A., Jones, A., Troyer, R. M., Bielefeldt‐Ohmann, H., & DOW, S. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900411 · Cited by 33
Dalgard, C. L., Eidelman, O., Jozwik, C., Olsen, C. H., Srivastava, M., Biswas, R., Eudy, Y., Rothwell, S. W., Mueller, G. P., Yuan, P., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.285 · Cited by 33
Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis
Zhou, H., Hu, B., Zhaopeng, Z., Liu, J., Zhong, Q., Fan, Y., & Li, L. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04465-w · Cited by 33
Kim, W.-K., Choi, E., Sul, O., Park, Y.-K., Kim, E.-S., Yu, R., Suh, J., & Choi, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072108 · Cited by 31
Lindholm, P. F. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000308 · Cited by 30
Siddiqui, K., Joy, S. S., George, T. P., Mujammami, M. H., & Alfadda, A. A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s282166 · Cited by 29
Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss
Hu, Y., Wang, L., Zhao, Z.-J., Lu, W., Fan, J., Gao, B., Luo, Z., Jie, Q., Shi, X., & Yang, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11543 · Cited by 28
Upregulated C-C Motif Chemokine Ligand 2 Promotes Ischemic Stroke via Chemokine Signaling Pathway
Li, L., Lou, W., Li, H., Zhu, Y., & Huang, X. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.04.047 · Cited by 27
Mohamed, H. T., Elghonaimy, E. A., El‐Shinawi, M., Hosney, M., Götte, M., Woodward, W. A., El‐Mamlouk, T., & Mohamed, M. M. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115092 · Cited by 26
Sierra, B., Pérez, A. B., Aguirre, E., Bracho, C., Valdés, O., Jiménez, N., Rodríguez, W. B., González, G., Ortega, L. M., Montalvo, M. C., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa407 · Cited by 25
Yoshimura, T., Galligan, C. L., Takahashi, M., Chen, K., Liu, M., Tessarollo, L., & Wang, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00482 · Cited by 23
Chen, W.-C., Wang, S., Lin, C., Tsai, C., Fong, Y., Lin, T.-Y., Weng, S.-L., Huang, H., Liao, K., & Tang, C. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000029 · Cited by 23
Investigation of the prognostic value of adipokines in multiple sclerosis
Çoban, A., Düzel, B., Tüzün, E., & Tamam, Y. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.04.006 · Cited by 22
The Significance of HCV Viral Load in the Incidence of HCC: a Correlation Between Mir-122 and CCL2
Nabih, H. K. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00281-2 · Cited by 20
Xu, Y., Shen, Y., Zhang, X. ‐., Gui, L., Cai, M., Peng, G., Pan, X. ‐., Zhang, J., Gan, D., Li, B., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14254 · Cited by 19
Yan, L., & Sundaram, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8364 · Cited by 18
Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus
Ansari, A. W., Schmidt, R. E., Shankar, E. M., & Kamarulzaman, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0341-8 · Cited by 16
Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome
Li, L., Ryoo, J. E., Lee, K.-J., Choi, B. C., & Baek, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123045 · Cited by 15
Wang, C., Yang, L., Zhang, J., Lin, Z., Qi, J., & Duan, S. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.07.033 · Cited by 15
The ‐ A2518G polymorphism in the MCP‐1 gene and inflammatory bowel disease risk: A meta‐analysis
Li, Y. W., Yang, C. Q., Xiao, Y., Li, J., Xie, C. X., Zhang, S., Yu, Q., Wang, H. L., Lu, W. M., & Chen, M. H. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12232 · Cited by 14
Protective Effect of the MCP-1 Gene Haplotype against Schizophrenia
Saoud, H., Inoubli, O., Fredj, S. B., Hassine, M., Mohamed, B. B., Gaha, L., & Jrad, B. B. H. (2019) · BioMed Research International · doi:10.1155/2019/4042615 · Cited by 14
Kobayashi, K., Yoshioka, T., Miyauchi, J., Nakazawa, A., Yamazaki, S., Ono, H., Tatsuno, M., Iijima, K., Takahashi, C., Okada, Y., et al. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000809 · Cited by 8
Tülübaş, F., Oran, M., Mete, R., Turan, F., Yılmaz, A., YILDIZ, Z. D., & Gürel, A. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1302-90 · Cited by 7
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson’s disease
Wang, Y., Zhou, M., Wang, Y., Jiang, D., & Deng, X. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02072-2 · Cited by 7
Cited by
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
Bai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
Role of MCP-1 as an inflammatory biomarker in nephropathy
Liu, Y., Xu, K., Xiang, Y., Ma, B., Li, H., Li, Y., Shi, Y., Li, S., & Bai, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303076 · Cited by 93
Endothelial Dysfunction as the Common Pathway Linking Obesity, Hypertension and Atherosclerosis
Młynarska, E., Bojdo, K., Frankenstein, H., Krawiranda, K., Kustosik, N., Lisińska, W., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010096 · Cited by 87
Zhang, H., Zheng, L., Li, C., Jing, J., Li, Z., Sun, S., Xue, T., Zhang, K., Xue, M., Cao, C., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01227-w · Cited by 27
Metadata
- Authors
- Singh, S., Anshita, D., & Ravichandiran, V.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 101
- Issue
- Pt B
- Pages
- 107598
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3163840476
- Cited by
- 883
- References
- 128
- FWCI
- 44.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.